Copy number gains that include the MYCN locus are detected in 12.7% of Wilms tumors and 30.4% of diffuse anaplastic Wilms tumors, and MYCN gain is associated with poorer relapse-free and overall survival (29). The gene discussed is MYCN; the disease is Nephroblastoma.